|
FUNDC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.97145999999426E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.75540000000507E-05 |
| Normal-vs-Stage2 |
8.162000E-01 |
| Normal-vs-Stage3 |
7.79929999999984E-05 |
| Normal-vs-Stage4 |
1.66160999999221E-05 |
| Stage1-vs-Stage2 |
3.303800E-03 |
| Stage1-vs-Stage3 |
4.237200E-01 |
| Stage1-vs-Stage4 |
8.041800E-02 |
| Stage2-vs-Stage3 |
4.285000E-03 |
| Stage2-vs-Stage4 |
6.632000E-04 |
| Stage3-vs-Stage4 |
3.569400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.46700000000799E-06 |
| Normal-vs-AfricanAmerican |
4.814200E-02 |
| Normal-vs-Asian |
6.553200E-04 |
| Caucasian-vs-AfricanAmerican |
6.969200E-01 |
| Caucasian-vs-Asian |
9.734800E-01 |
| AfricanAmerican-vs-Asian |
7.111400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59280000000539E-06 |
| Normal-vs-Female |
1.645840E-04 |
| Male-vs-Female |
7.492400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.645980E-04 |
| Normal-vs-Age(41-60Yrs) |
1.167150E-04 |
| Normal-vs-Age(61-80Yrs) |
2.964100E-03 |
| Normal-vs-Age(81-100Yrs) |
3.463700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.739600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.634800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.259800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.734800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.789800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.579400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.010300E-04 |
| Classical-VS-Follicular |
9.037700E-03 |
| Classical-VS-Other |
2.996000E-01 |
| Classical-VS-Normal |
4.180999999992E-06 |
| Tall-VS-Follicular |
1.26899999997043E-06 |
| Tall-VS-Other |
7.793200E-01 |
| Tall-VS-Normal |
1.63629998439774E-09 |
| Follicular-VS-Other |
1.196400E-01 |
| Follicular-VS-Normal |
3.559200E-01 |
| Other-VS-Normal |
8.574100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.102700E-03 |
| Normal-vs-N1 |
8.58119997282358E-09 |
| N0-vs-N1 |
4.607000E-04 |
|
|
